Senior Director, Commercial Product Strategy HIV Treatment
Gilead Sciences
Summary
As a Senior Director, Global Strategic Marketing Lead HIV Treatment at Gilead is a pivotal global commercial leadership role shaping the launch and long-term success of HIV Treatment products across the G9 markets. This position plays a critical role in defining strategy, accelerating launch readiness, and driving global alignment to maximize patient impact and business performance. You will serve as a strategic leader within the HIV franchise, partnering across Commercial, Medical Affairs, Clinical Development, Value & Access, Analytics, Public Affairs, Government Affairs, and regional stakeholders to develop and execute a differentiated global strategy. This position is based onsite at Gilead's headquarters in Foster City, California. Remote work is not available for this role.
Job description
Global Launch & Commercial Strategy
- Lead the global go-to-market strategy for HIV Treatment, including brand positioning, value proposition, messaging architecture, and campaign strategy.
- Develop and drive integrated global launch and indication strategies that support market access, regulatory requirements, and country-level execution.
- Ensure global strategic priorities inform and enable successful local commercialization plans.
Strategic Insight & Business Leadership
- Translate complex market, competitive, customer, and product insights into actionable commercial strategies and business recommendations.
- Identify unmet needs and opportunities that strengthen brand differentiation and drive market adoption.
- Contribute to HIV portfolio strategy and cross-brand positioning efforts.
Enterprise Cross-Functional Leadership
- Partner across functions and geographies to align stakeholders around launch objectives and strategic priorities.
- Influence decision-making by building strong partnerships with global and regional teams.
- Drive execution excellence across multiple workstreams while ensuring compliance with regulatory and corporate requirements.
Commercial Planning & Performance
- Support development of earnings call materials, forecasts, long-range planning activities, and leadership guidance.
- Lead development and implementation of innovative commercial initiatives aligned with brand objectives and growth priorities.
- Monitor strategic execution and adjust plans to address evolving market dynamics and business needs.
Operational Excellence
- Lead complex projects with accountability for quality, timelines, budget management, and stakeholder alignment.
- Foster disciplined execution and continuous improvement across launch and commercialization activities.
Requirements
- Bachelor's degree in Business, Life Sciences, Marketing, or related field and 14 years' relevant experience; OR Master's degree and 12 years' relevant experience; OR PhD and 12 years' relevant experience.
- MBA, advanced life sciences degree, or medical degree preferred.
- HIV therapeutic area expertise preferred.
- Global product launch experience preferred.
- Country-level marketing leadership or business unit leadership experience preferred.
- Experience working across diverse global markets and cultures preferred.
- Demonstrated success in multi-channel marketing and global pharmaceutical planning preferred.
- Experience supporting forecasting, long-range planning, and executive communications preferred.
- Background in management consulting, business transformation, or change management preferred.
- Advanced proficiency using Microsoft Word, Excel, and PowerPoint preferred.
Benefits
- Medical, Dental & Vision
- Life Insurance
- Paid Time Off
- Discretionary Annual Bonus
- Stock-Based Long-Term Incentives
Company overview
Gilead Sciences, Inc. is a leading American biopharmaceutical company headquartered in Foster City, California, that specializes in researching, developing, and commercializing innovative medicines for life-threatening diseases. Founded in 1987, Gilead has grown into a global healthcare leader with approximately 17,600 employees worldwide. The company's primary therapeutic focus areas include HIV/AIDS, viral hepatitis (hepatitis B and C), oncology, inflammation, and respiratory diseases. Gilead is renowned for its groundbreaking antiviral therapies, including Sovaldi and Harvoni for hepatitis C, and its comprehensive portfolio of HIV treatments such as Truvada, Atripla, and Biktarvy. The company also developed Veklury (remdesivir) for COVID-19 treatment. Gilead operates as a publicly traded company on the NASDAQ (GILD) and is a component of both the Nasdaq-100 and S&P 100 indices. Through strategic acquisitions like Kite Pharma and Immunomedics, Gilead has expanded into cell therapy and oncology, demonstrating its commitment to advancing medical science and improving patient outcomes globally.